Jiangsu Historical Cash Flow
| 688670 Stock | 27.40 1.92 6.55% |
Analysis of Jiangsu GDK cash flow over time is an excellent tool to project Jiangsu GDK Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 56.8 M or Depreciation of 28.4 M as it is a great indicator of Jiangsu GDK ability to facilitate future growth, repay debt on time or pay out dividends.
Jiangsu |
About Jiangsu Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Jiangsu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jiangsu's non-liquid assets can be easily converted into cash.
Jiangsu GDK Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Jiangsu GDK Biotechnology to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Jiangsu GDK operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Jiangsu GDK's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Jiangsu GDK Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu GDK Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. The current year's Investments is expected to grow to about 153.9 M, whereas Change To Inventory is forecasted to decline to (34.5 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 168.2M | 54.0M | 38.5M | 36.6M | Dividends Paid | 45.3M | 19.5M | 1.6M | 1.5M |
Jiangsu GDK cash flow statement Correlations
Click cells to compare fundamentals
Jiangsu GDK Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jiangsu GDK cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (14.8M) | (48.9M) | (39.0M) | (44.8M) | (32.9M) | (34.5M) | |
| Change In Cash | 80.5M | (51.3M) | 138.0M | (104.3M) | (2.8M) | (2.7M) | |
| Free Cash Flow | 68.6M | (282.5M) | (129.6M) | 26.9M | (169.9M) | (161.4M) | |
| Change In Working Capital | (112.3M) | (70.3M) | (61.3M) | 87.2M | (85.1M) | (89.3M) | |
| Begin Period Cash Flow | 7.6M | 88.0M | 36.7M | 174.7M | 70.4M | 52.5M | |
| Other Cashflows From Financing Activities | 139M | 185.2M | 1.4B | 52M | 59.8M | 56.8M | |
| Depreciation | 25.8M | 28.1M | 29.8M | 29.9M | 30.0M | 28.4M | |
| Other Non Cash Items | 40.9M | 63.7M | 28.6M | 3.3M | 2.0M | 1.9M | |
| Dividends Paid | 8.4M | 9.9M | 45.3M | 19.5M | 1.6M | 1.5M | |
| Capital Expenditures | 40.8M | 386.4M | 168.2M | 54.0M | 38.5M | 36.6M | |
| Total Cash From Operating Activities | 109.5M | 103.9M | 38.6M | 80.9M | (131.4M) | (124.8M) | |
| Net Income | 155.0M | 82.5M | 41.5M | (71.0M) | (93.5M) | (88.8M) | |
| Total Cash From Financing Activities | 82.3M | 42.3M | 841.1M | (13.3M) | (15.2M) | (14.5M) | |
| End Period Cash Flow | 88.0M | 36.7M | 174.7M | 70.4M | 67.6M | 61.7M | |
| Investments | (71.3M) | (996.4M) | 112.7M | (187.7M) | 146.6M | 153.9M |
Currently Active Assets on Macroaxis
Other Information on Investing in Jiangsu Stock
The Cash Flow Statement is a financial statement that shows how changes in Jiangsu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Jiangsu's non-liquid assets can be easily converted into cash.